Coronary Stents Market Report 2026

Coronary Stents Market Overview

• Coronary Stents market size has reached to $11.9 billion in 2025 • Expected to grow to $17.76 billion in 2030 at a compound annual growth rate (CAGR) of 8.3% • Growth Driver: Rising Prevalence Of Cardiovascular Diseases To Drive Growth In Coronary Stent Market • Market Trend: Innovative Advancements In Coronary Stents • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Coronary Stents Market?

Coronary stents are small, expandable tubes used to open up narrowed or blocked coronary arteries, which supply blood to the heart muscle. These devices are typically made of metal mesh and are placed during a procedure called percutaneous coronary intervention (PCI), often referred to as angioplasty. The stent is inserted into the artery on a balloon catheter and expanded at the site of the blockage to restore proper blood flow. The main coronary stents are dual therapy stents, radioactive stents, thrombectomy stents, covered stents, bioresorbable stents, biodegradable stents, hybrid stents, drug-eluting stents, and bare metal stents. Dual therapy stents combine drug-eluting and bioresorbable technologies to provide both medication release and gradual absorption of the stent structure. It uses several technologies, such as laser cutting, 3D-printed stents, microfabrication, nanotechnology-based stents, electropolishing, and others, and is made of various raw materials, including cobalt-chromium, stainless steel, platinum-chromium, and nickel-titanium. It can be both self-expandable stents and balloon-expandable stent deployment, and it is used by several end users, such as hospitals, ambulatory surgical centers, specialty clinics, and others.

What Is The Coronary Stents Market Growth Forecast?

The coronary stents market size is expected to see strong growth in the next few years. It will grow to $17.76 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to aging population with higher cardiovascular risk, increasing demand for minimally invasive cardiac treatments, growing adoption of next-generation stent technologies, rising focus on long-term vessel healing and patient outcomes, expanding access to cardiac care in emerging markets. Major trends in the forecast period include rising adoption of drug-eluting and dual therapy stents, increasing preference for minimally invasive coronary interventions, growing focus on reducing restenosis and thrombosis risks, expansion of bioresorbable and biodegradable stent usage, increasing demand for advanced stent materials and designs.

Global Coronary Stents Market Segmentation

1) By Product Type: Dual Therapy Stents, Radioactive Stents, Thrombectomy Stents, Covered Stents, Bioresorbable Stents, Biodegradable Stents, Hybrid Stents, Drug-Eluting Stents, Bare Metal Stents 2) By Technology: Laser Cutting, 3D-Printed Stents, Microfabrication, Nanotechnology-Based Stents, Electropolishing, Others Technologies 3) By Raw Material: Cobalt-Chromium, Stainless Steel, Platinum–Chromium, Nickel–Titanium, Polymer 4) By Deployment: Self-Expandable Stents, Balloon-Expandable Stents 5) By End Uses: Hospitals And Ambulatory Surgical Centers, Specialty Clinics, Other End Uses Subsegments: 1) By Dual Therapy Stents: Sirolimus-Eluting Dual Therapy Stents, Paclitaxel-Eluting Dual Therapy Stents, Everolimus-Eluting Dual Therapy Stents 2) By Radioactive Stents: Beta Radiation Stents, Gamma Radiation Stents, Other Radiation Stents 3) By Thrombectomy Stents: Manual Thrombectomy Stents, Mechanical Thrombectomy Stents, Hydrodynamic Thrombectomy Stents 4) By Covered Stents: PTFE-Covered Stents, ePTFE-Covered Stents, Polyurethane-Covered Stents, Other Covered Stents 5) By Bioresorbable Stents: Polymer-Based Bioresorbable Stents, Metal-Based Bioresorbable Stents, Ceramic-Based Bioresorbable Stents 6) By Biodegradable Stents: Polymeric Biodegradable Stents, Magnesium-Based Biodegradable Stents, Other Biodegradable Stents 7) By Hybrid Stents: Hybrid Drug-Eluting Stents, Hybrid Biodegradable Or Metal Stents, Other Hybrid Stents 8) By Drug-Eluting Stents: Sirolimus-Eluting Stents, Paclitaxel-Eluting Stents, Everolimus-Eluting Stents, Zotarolimus-Eluting Stents, Other Drug-Eluting Stents 9) By Bare Metal Stents: Stainless Steel Bare Metal Stents, Cobalt Chromium Bare Metal Stents, Other Bare Metal Stents

What Is The Driver Of The Coronary Stents Market?

The rising prevalence of cardiovascular diseases (CVDs) is expected to propel the growth of the coronary stent market going forward. Cardiovascular diseases are a group of disorders of the heart and blood vessels, including conditions such as coronary artery disease, heart failure, stroke, and hypertension. Cardiovascular diseases are rising due to factors like an aging population, an increased prevalence of risk factors such as obesity, diabetes, sedentary lifestyles, a poor diet, and stress. A coronary stent is required for cardiovascular diseases to open narrowed or blocked coronary arteries, improving blood flow to the heart and reducing the risk of heart attacks. For instance, in October 2024, according to the Centers for Disease Control and Prevention, is a US-based, government agency, in 2023, cardiovascular disease claimed 919,032 lives, accounting for approximately one in every three deaths.Therefore, the rising prevalence of cardiovascular diseases (CVDs) is driving the growth of the coronary stent industry.

Key Players In The Global Coronary Stents Market

Major companies operating in the coronary stents market are Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, BIOTRONIK SE & Co KG, B Braun Melsungen AG, Biosensors International Group Ltd, MicroPort Scientific Corporation, Lepu Medical Technology Beijing Co Ltd, Meril Life Sciences Pvt Ltd, Stentys SA, Alvimedica, Vascular Concepts, Balton Medical, Cardionovum, HEXACATH, Elixir Medical Corporation, Translumina GmbH, Relisys Medical Devices Ltd, REVA Medical Inc, Sahajanand Medical Technologies Pvt Ltd, Endocor GmbH, Eurocor Tech, Medinol, Q3 Medical Devices, S3V Vascular Technologies, InSitu Technologies, Minvasys

Global Coronary Stents Market Trends and Insights

Major companies operating in the coronary stent market are developing innovative products, such as drug-eluting stents, to reduce the need for repeat procedures compared to bare-metal stents. Drug-eluting stents are specialized coronary stents coated with medication designed to prevent the re-narrowing of arteries by releasing drugs gradually over time. For instance, in May 2024, Abbott, a US-based healthcare company, launched the XIENCE Sierra Everolimus (drug) Eluting Coronary Stent System in India. The XIENCE Sierra stent stands out due to its enhanced design, new delivery system, and unique size options, specifically engineered to address challenging cases. It retains the specialized coating that reduces the risk of artery re-blockage, consistent with other XIENCE stents. This stent benefits from an exceptional safety record, backed by over 120 clinical trials involving more than 120,000 patients.

What Are Latest Mergers And Acquisitions In The Coronary Stents Market?

In November 2023, OrbusNeich Medical Group Holdings Limited, a China-based medical device company, acquired Eucatech AG for an undisclosed amount. With this acquisition, OrbusNeich aims to expand its cardiovascular product portfolio, strengthen its position in the global angioplasty and stent markets, accelerate innovation in vascular intervention solutions, and enhance its commercial presence across Europe and other key regions. Eucatech AG is a Germany-based medical device company that offers coronary stents.

Regional Outlook

North America was the largest region in the coronary stents market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Coronary Stents Market?

The coronary stent market consists of revenues earned by entities by providing services such as product training and education, technical support, clinical support, research and development, customized solutions. The market value includes the value of related goods sold by the service provider or included within the service offering. The coronary stent market also includes sales of covered stents, balloon catheters, guidewires, embolic protection devices and imaging systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.